Post Marketing Surveillance and Special Studies
Post-marketing surveillance (PMS) and special studies are two important components of drug and medical device regulation. PMS involves ongoing monitoring of the safety and efficacy of a product after it has been approved for marketing and sale, while special studies are focused studies conducted on a specific aspect of a product’s safety or efficacy.
Post-marketing surveillance is a critical component of the overall regulatory framework for drugs and medical devices. The objective of PMS is to identify any new safety or efficacy concerns that may arise after a product has been approved for use. This helps to ensure that the benefits of a product continue to outweigh the risks, and that appropriate actions are taken to address any safety concerns that may emerge.
Special studies, on the other hand, are focused studies that are conducted to answer specific questions about a product’s safety or efficacy. These studies may be conducted at the request of regulatory agencies, or may be initiated by the manufacturer to address specific concerns or to gather additional information about a product.
Both PMS and special studies are important components of the overall regulatory framework for drugs and medical devices. They help to ensure that the benefits of these products continue to outweigh the risks, and that appropriate actions are taken to address any safety concerns that may arise.
In conclusion, post-marketing surveillance and special studies play a critical role in ensuring the safety and efficacy of drugs and medical devices, and are an important part of the ongoing regulatory process for these products.
You may be interested in the programs below:
